HC
Therapeutic Areas
Enliven Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ELVN-001 | Chronic Myeloid Leukemia (CML) | Phase 1b |
Leadership Team at Enliven Therapeutics
RF
Rick Fair
Chief Executive Officer and Member of the Board of Directors
SK
Sam Kintz
Co-founder and Head of Pipeline
JL
Joe Lyssikatos
Co-founder and Chief Scientific Officer
AP
Anish Patel
Co-founder and Chief Operating Officer
BH
Ben Hohl
Chief Financial Officer and Head of Corporate Development
GB
Galya Blachman
Chief Legal Officer and Head of Business Development